RNA Analysis/ Transcriptomics Market Report 2026

RNA Analysis/ Transcriptomics Market Overview

• RNA Analysis/ Transcriptomics market size has reached to $8.74 billion in 2025 • Expected to grow to $19.04 billion in 2030 at a compound annual growth rate (CAGR) of 16.8% • Growth Driver: Surging Chronic Disease Rates Fuel Rna Analysis Market Growth • Market Trend: Rna Analysis Market Sees Major Companies Expanding Innovative Portfolios • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under RNA Analysis/ Transcriptomics Market?

Transcriptomics/RNA analysis is a study of the transcriptome under specific circumstances, environment, or in a specific cell using high-throughput methods. It is used to understand gene expression patterns, cellular responses, and the molecular mechanisms underlying various biological processes and diseases. The main types of products in the RNA analysis/ transcriptomics market are reagents/consumables, instruments, and software. It is implemented in various areas including clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference. Major technology involved in RNA analysis/ transcriptomics are microarrays, sequencing, polymerase chain reaction RNA interference. RNA analysis is used in clinical diagnosis to detect different RNA species, and pathogen RNA splice variants among others useful in the diagnosis of diseases.

What Is The RNA Analysis/ Transcriptomics Market Growth Forecast?

The rna analysis/ transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $19.04 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine applications, rising use of transcriptomics in drug discovery, expansion of clinical diagnostics based on gene expression, growing investments in bioinformatics infrastructure, increasing focus on personalized therapeutics. Major trends in the forecast period include increasing adoption of next-generation sequencing platforms, rising use of high-throughput transcriptomic profiling, growing integration of advanced bioinformatics tools, expansion of single-cell rna analysis techniques, enhanced focus on reproducibility and data accuracy.

Global RNA Analysis/ Transcriptomics Market Segmentation

1) By Product: Reagents/Consumables, Instruments, Software 2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction 3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference Subsegments: 1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits 2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers 3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems

What Is The Driver Of The RNA Analysis/ Transcriptomics Market?

The rising prevalence of chronic diseases is expected to propel the growth of the RNA analysis/ transcriptomics market going forward. Chronic diseases refer to ailments that last for a year or longer, impede everyday activities, require continuing medical care, or both. Rising prevalence of chronic diseases is primarily due to increasingly sedentary lifestyles, as lower daily physical activity weakens metabolic health and elevates the likelihood of developing long-term illnesses. RNA analysis/transcriptomics helps chronic diseases by revealing disease-driving gene activity changes, enabling earlier detection, more accurate diagnosis, and the development of targeted, personalized treatments. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing incidence of chronic diseases is driving the growth of the RNA analysis/ transcriptomics industry.

Key Players In The Global RNA Analysis/ Transcriptomics Market

Major companies operating in the rna analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

Global RNA Analysis/ Transcriptomics Market Trends and Insights

Major companies operating in the RNA analysis/ transcriptomics market are increasing their focus on introducing innovative portfolios to gain a competitive edge in the market. The RNA Portfolio involves the development of new technologies and solutions that are designed to improve the efficiency and effectiveness of RNA analysis. For instance, in May 2023, Twist Bioscience Corporation, a US-based biotechnology company, announced the launch of a portfolio of RNA sequencing tools that contains specific target enrichment capabilities for RNA and whole transcriptome sequencing, as well as the Twist RNA Exome, Twist RNA Library Prep Kit, and Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit. The portfolio offers complete workflows for analyzing messenger RNA (mRNA) protein coding sequences, custom targets, and total RNA for the purpose of measuring the transcriptome. Additionally, these goods can be included in the current workflows of their clients.

What Are Latest Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market?

In August 2024, Danaher Corporation, a US-based global science and technology innovator specializing in life sciences and diagnostics, acquired Genedata AG for an undisclosed amount. Through this acquisition, Danaher Corporation aims to strengthen its portfolio by integrating Genedata’s advanced bioinformatics and multi-omics data-analysis platforms into its expanding suite of research and bioprocessing solutions. Genedata has established itself as a market leader in enterprise-level analytics software for transcriptomics, genomics, and other complex biological data, and this acquisition will further enhance Danaher’s capabilities in accelerating biologics discovery, development, and manufacturing. Genedata AG is a Switzerland-based bioinformatics company providing high-throughput data-analysis solutions that streamline RNA-sequencing workflows and support large-scale omics research across leading biopharmaceutical organizations.

Regional Outlook

North America was the largest region in the RNA analysis/transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the RNA Analysis/ Transcriptomics Market?

The RNA analysis/ transcriptomics market includes revenues earned by entities by providing services such as Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Microarray Analysis, Sanger Sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.